跳至主要内容
临床试验/ACTRN12623000052639
ACTRN12623000052639招募中未知

Investigating the effect of multidisciplinary prehabilitation on deconditioning, hospital acquired complications and length of stay in patients offered Haematopoietic allogenic stem cell transplant: A feasibility trial.

RAH Haematology Clinical Trials & Cancer Haematology0 个研究点目标入组 20 人开始时间: 2023年1月17日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Prevention
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Participants must be aged 18 years of age or older.
  • Diagnosed with Acute myeloid leukemia (AML)/Myelodysplastic Syndrome (MDS) and offered allo-HSCT at the RAH.
  • Medically stable (as determined by absolute contraindications to exercise as per national and international exercise guidelines (Exercise and Sports Science Australia, American College of Sports Medicine)) and have written clearance from their consultant haematologist.

排除标准

  • Cognitive impairment severe enough to limit participation in the prehab program (as determined by a medical practitioner).
  • Any absolute contraindications to exercise (as per written medical clearance), for example unstable angina or uncontrolled heart failure. Patients with permanent pacemaker will be excluded from bio-electrical impedance spectroscopy.

研究者

发起方
RAH Haematology Clinical Trials & Cancer Haematology

相似试验